Monitoring and Testing of Blood Pressure in Postpartum Women
SMART-BP
Systematic Monitoring and Remote Testing of Blood Pressure in Postpartum Women
1 other identifier
interventional
1,607
1 country
1
Brief Summary
The purpose of this research study is to find out the usefulness of checking a woman's blood pressure remotely (at home) for 3 weeks after being discharged from the hospital after having a baby (or babies). Some women can develop hypertension, or high blood pressure, after delivery even if they have not had this problem before or during their pregnancy. Untreated or unknown high blood pressure can lead to medical complications, and if severe, can be life threatening. Monitoring, or checking, remote blood pressure after a woman has delivered her baby (or babies) has been suggested to be a better way to monitor blood pressures without having to stay in the hospital for a longer time after delivery. Other researchers report that women who have checked their blood pressure remotely after delivery found out that this was both possible and acceptable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Mar 2022
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2022
CompletedFirst Posted
Study publicly available on registry
February 11, 2022
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2025
CompletedResults Posted
Study results publicly available
March 2, 2026
CompletedMarch 19, 2026
September 1, 2025
2.9 years
January 28, 2022
January 7, 2026
February 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Median Number of Remote Blood Pressure (rBPM) Measurements Obtained Per Participant
Used to determine feasibility of remote blood pressure monitoring intervention (rBPM) in postpartum women. This measure represents the median number of remote blood pressure monitoring (rBPM) measurements collected per participant during the study period. The total number of rBPM readings obtained for each participant was calculated, and the median value across all participants in the analysis population was reported
Discharge through Week 3 postpartum
Proportion of Participants Monitoring Blood Pressure (BP) According to American College of Obstetricians and Gynecologists (ACOG) Guidelines
This outcome measures the proportion of participants whose postpartum blood pressure monitoring adhered to American College of Obstetricians and Gynecologists (ACOG) recommendations. Adherence includes: Initial Monitoring (first 72 hours postpartum): inpatient or equivalent monitoring for women with pregnancy-related hypertension; and Early Follow-Up (3-10 days postpartum): documentation of a follow-up visit or remote blood pressure check within 3-10 days after hospital discharge. Monitoring data will be obtained from electronic health records and remote blood pressure monitoring logs. Participants are counted once if they met both ACOG-recommended monitoring intervals.
Discharge through Day 10 postpartum
Median Total Cost of Health Care
Cost of hospital based medical care of subjects in US dollars.
From discharge through week 8 postpartum
Number of Participants Experiencing at Least One Day With a Severe Hypertension Event
This measure captures the number of participants who experienced one or more days in which a severe hypertension event occurred. A participant is counted once if they had ≥1 day meeting severe hypertension criteria, regardless of the total number of qualifying days. A severe or critical hypertensive event is defined as any blood pressure reading in which the systolic value is ≥160 mmHg and/or the diastolic value is ≥110 mmHg.
Discharge through week 1 postpartum
Number of Participants Experiencing at Least One Day With a Severe Hypertension Event
This measure captures the number of participants who experienced one or more days in which a severe hypertension event occurred. A participant is counted once if they had ≥1 day meeting severe hypertension criteria, regardless of the total number of qualifying days. A severe or critical hypertensive event is defined as any blood pressure reading in which the systolic value is ≥160 mmHg and/or the diastolic value is ≥110 mmHg.
Discharge through week 3 postpartum
Number of Participants With One or More Urgent or Emergent Care Encounters
The study team will use the electronic health record (EHR) to identify the number of participants who had one or more encounters at Emergency Department, Obstetric Triage, or Urgent Care facilities affiliated with Atrium Health Wake Forest Baptist. Encounters will be identified using visit type classifications and associated encounter codes documented in the EHR. Only encounters occurring within the specified study time frame and attributable to enrolled participants will be included. Each participant will be counted once regardless of the total number of urgent or emergent care visits they experienced.
Discharge through week 3 postpartum
Secondary Outcomes (6)
Median Number of Encounters for Urgent or Emergent Care
Discharge through week 8 postpartum
Acceptability of rBPM in Postpartum Period
Week 3 postpartum
Median Length of Stay (LOS) in Hospital After Delivery
Baseline (date of delivery) through discharge, assessed for up to 8 weeks postpartum
Median Number of Hospital Readmissions
Discharge through week 8 postpartum
Median Length of Stay (LOS) for Hospital Readmissions
Discharge through week 8 postpartum
- +1 more secondary outcomes
Other Outcomes (1)
Validate and Calibrate Previously Developed Predictive Algorithm
Discharge through week 8 postpartum
Study Arms (2)
Standard of Care (SOC)
NO INTERVENTIONSubjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or Atrium Health Wake Forest Baptist Maternal-Fetal Medicine provider)
Remote Blood Pressure Monitoring (rBPM)
EXPERIMENTALSubjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote blood pressure monitoring app (BabyScripts) and Bluetooth enabled blood pressure cuff/monitor, and will receive the following equipment and monitoring: * a specialized, Bluetooth enabled blood pressure monitoring cuff (Clinically Validated, A\&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2) * Blood pressure monitoring smart phone app, BabyScripts™ * Verbal and written instructions, to conduct blood pressure checks at home
Interventions
specialized, Bluetooth enabled blood pressure monitoring cuff
Verbal and written instructions to conduct blood pressure checks at home
app that works with the monitoring cuff
Eligibility Criteria
You may qualify if:
- Women that received prenatal care at one of the Atrium Health Wake Forest Baptist Obstetrics/Maternal-Fetal Medicine outpatient clinic locations in Forsyth County, North Carolina
- Women that delivered an infant(s) at The Birth Center at Atrium Health Wake Forest Baptist
- Women that delivered an infant(s) at home or outside facility, and were transported to Atrium Health Wake Forest Baptist and received postpartum care in The Birth Center
- Currently resides in Forsyth County, North Carolina
- Able to read and understand either English or Spanish
- Owns or has daily access to a smart phone (iOS or Android operating system) with available Wi-Fi or monthly mobile data plan
You may not qualify if:
- Women that received postpartum care at any location other than The Birth Center at Atrium Health Wake Forest Baptist
- Resides outside of Forsyth County, North Carolina
- Under 18 years of age
- Unable to read or understand either English or Spanish
- Does not own or have daily access to a smart phone (iOS or Android operating system) with available Wi-Fi or monthly mobile data plan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Elizabeth T. Jensen, MPH PhD, Professor of Epidemiology
- Organization
- Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth T Jensen, MPH PhD
Atrium Health Wake Forest Baptist
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2022
First Posted
February 11, 2022
Study Start
March 1, 2022
Primary Completion
January 7, 2025
Study Completion
November 12, 2025
Last Updated
March 19, 2026
Results First Posted
March 2, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share